Eastern District of Texas deals blow to generic pharmaceutical companies

“In one of the first Eastern District of Texas interpretations of the Hatch-Waxman Act, the federal law governing the procedure for bringing generic drugs to market, brand-name drug company Allergan Inc. has prevailed against five generic drug makers.”

To read the full article produced by the New York Law Journal, please click here.